TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) › Total LiabilitiesTEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) — Total LiabilitiesAnnual figures by fiscal year, from SEC filings.2008: $16.48B2009: $13.95B2010: $16.15B2011: $27.80B2012: $27.74B2013: $24.87B2017: $51.87B2018: $44.89B2019: $42.41B2020: $39.58B2021: $36.42B2022: $35.41B2023: $35.35B2024: $33.61B2025: $32.83B$32.83B2008Total Liabilities (USD)2025Fiscal YearTotal LiabilitiesChange YoY2025$32.83B-2.3%2024$33.61B-4.9%2023$35.35B-0.2%2022$35.41B-2.8%2021$36.42B-8.0%2020$39.58B-6.7%2019$42.41B-5.5%2018$44.89B-13.5%2017$51.87B—2013$24.87B-10.3%2012$27.74B-0.2%2011$27.80B+72.1%2010$16.15B+15.8%2009$13.95B-15.4%2008$16.48B—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share